Gilead has been, is, and will be here to fight alongside policymakers, nurses, clinicians and campaigners striving to stop the virus. And we stand beside every person living with HIV today, with the knowledge that we all have something to contribute.
Without relentless collaboration and partnership, we could not have come this far. With it we can move forward together, faster, ensuring we leave no one behind.
Together we can change more lives. Together we can stop the virus.
This website has been created by Gilead for the purposes of disease education and awareness.
In an effort to fight the HIV epidemic globally, the International Association of Providers of AIDS Care IAPAC, the Joint United Nations Programme on HIV/AIDS (UNAIDS), the United Nations Human Settlements Programme (UN-Habitat) and the City of Paris, joined forces in 2014 and endorsed the Paris Declaration.
This website has been created by Gilead for the purposes of disease education and awareness.
Gilead Sciences Germany is committed to supporting national efforts to contain and ultimately end the HIV epidemic once and for all. Together with partner organizations, Gilead intends to build on the progress achieved so far, to accelerate the fight against HIV, while at the same time supporting people with HIV to live well at every stage of life.
This website has been created by Gilead for the purposes of disease education and awareness.
Those who have worked in or lived with HIV are no strangers to a pandemic and the challenges associated with the public health fight against viruses. While striving to end the HIV epidemic globally by 2030, the deadline set by the United Nations (UN) Sustainable Development Goal 3(SDGs)1, the UK has learned some lessons that are not only pertinent for HIV but for COVID-19 too.
This website has been created by Gilead for the purposes of disease education and awareness.
Despite making fewer headlines than in previous decades, the HIV epidemic in Europe is far from being a thing of the past. It will still be around to taunt us, as we learn to cope with yet another deadly virus.
This website has been created by Gilead for the purposes of disease education and awareness.
Today, HIV is no longer a death sentence. Continued scientific innovation has brought significant progress to treatment of HIV, improving the lives of people living with HIV (PLHIV) globally. Over the years, the prevalence of HIV/AIDS is evolving, and in Belgium new infections are decreasing1.
This website has been created by Gilead for the purposes of disease education and awareness.
In 2011, Gilead Sciences launched the "Pozytywnie Otwarci" (Positively Open) fellowship programme aimed at addressing the HIV knowledge gap and tackling stigma and discrimination against people living with HIV in Poland.
This website has been created by Gilead for the purposes of disease education and awareness.
Romania recently made an assessment of the past thirty years, since the breakout of a phenomenon that can be classified as an epidemiologic accident, when thousands of children in Romanian orphanages were infected with HIV. Back then, the specialists had to take unprecedented measures and test solutions to a major problem that all other countries knew too little about.
This website has been created by Gilead for the purposes of disease education and awareness.
“With a global prevalence approaching 37 million1 and an average age that continues to grow,2 more and more focus has been given to the lifelong good health of people living with HIV (PLHIV).
This website has been created by Gilead for the purposes of disease education and awareness.
It has been more than three decades since the global HIV/AIDS epidemic emerged, igniting a worldwide response and unifying a strong community to fight against the disease. Due to this effort, the global community now has the tools to meaningfully address new HIV Infections. Yet, in Eastern Europe and Central Asia (EECA), the HIV epidemic is still on the rise, 1 with more than 400 people becoming infected with HIV and 100 dying from AIDS every day in the region. 2
This website has been created by Gilead for the purposes of disease education and awareness.
Worldwide, women account for more than half the number of people living with HIV.1 Young women are twice as likely to acquire HIV as young men the same age – underscoring the degree of vulnerability that remains for many women around the world.1 On 10 September, at the Fast-Track Cities global conference in London, we held a symposium bringing together key policymakers and activists to explore solutions to address gender disparities in HIV.
You are now leaving www.stopthevirus and visiting a new site which is not owned or controlled by Gilead Sciences Europe. Gilead Sciences Europe is therefore not responsible for your interactions with the website or the information it provides.
Cancel Follow link